BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND Neurokinin
23 results:

  • 1. Multiple-day administration of fosaprepitant combined with tropisetron and olanzapine improves the prevention of nausea and vomiting in patients receiving chemotherapy prior to autologous hematopoietic stem cell transplant: a retrospective study.
    Ye P; Pei R; Wang T; Cao J; Zhang P; Chen D; Liu X; Du X; Li S; Tang S; Hu Y; Jiang L; Lu Y
    Ann Hematol; 2022 Aug; 101(8):1835-1841. PubMed ID: 35668198
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A prospective audit on the use of prophylactic antiemetics and rates of CINV in patients receiving carboplatin AUC≥4 or combination anthracycline-cyclophosphamide.
    Lo E; Anderson M; Carroll R; Forgeson G; Isaacs R; Jordan J; Satterthwaite L; Wewala N; Fernando J
    N Z Med J; 2021 Apr; 134(1533):33-45. PubMed ID: 33927422
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. lymphoma Occurring During Pregnancy: Current Diagnostic and Therapeutic Approaches.
    Shah MR; Brandt JS; David KA; Evens AM
    Curr Oncol Rep; 2020 Aug; 22(11):113. PubMed ID: 32804274
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Efficacy and safety of multiple doses of NEPA without dexamethasone in preventing nausea and vomiting induced by multiple-day and high-dose chemotherapy in patients with non-Hodgkin's lymphoma undergoing autologous hematopoietic stem cell transplantation: a phase IIa, multicenter study.
    Di Renzo N; Musso M; Scimè R; Cupri A; Perrone T; De Risi C; Pastore D; Guarini A; Mengarelli A; Benedetti F; Mazza P; Capria V; Chiusolo P; Cupelli L; Federico V; Bozzoli V; Messa AR; Codega P; Bonizzoni E; Specchia G
    Bone Marrow Transplant; 2020 Nov; 55(11):2114-2120. PubMed ID: 32346078
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. What are new treatment concepts in systemic itch?
    Kremer AE
    Exp Dermatol; 2019 Dec; 28(12):1485-1492. PubMed ID: 31452276
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Peripheral neuropathy in non-Hodgkin's lymphoma patients receiving vincristine with and without aprepitant/fosaprepitant.
    Edwards JK; Bossaer JB; Lewis PO; Sant A
    J Oncol Pharm Pract; 2020 Jun; 26(4):809-813. PubMed ID: 31446866
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prophylactic Antiemetics for Haematological Malignancies: Prospective Nationwide Survey Subset Analysis in Japan.
    Yoshida I; Tamura K; Miyamoto T; Shimokawa M; Takamatsu Y; Nanya Y; Matsumura I; Gotoh M; Igarashi T; Takahashi T; Aiba K; Kumagai K; Ishizawa K; Kurita N; Usui N; Hatake K
    In Vivo; 2019; 33(4):1355-1362. PubMed ID: 31280230
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Clinical Pharmacology Research for Promoting Individualized Cancer Chemotherapy].
    Watanabe H; Uchida M; Masuda S
    Yakugaku Zasshi; 2019; 139(6):901-909. PubMed ID: 31155534
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Aprepitant for the Treatment of Pruritus in Sézary Syndrome: A Randomized Crossover Clinical Trial.
    Zic JA; Straka BT; McGirt LY; Nian H; Yu C; Brown NJ
    JAMA Dermatol; 2018 Oct; 154(10):1221-1222. PubMed ID: 30140912
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. MALT lymphoma, Stress Ulcer and Cholinergic Nerves from the Viewpoint of Bilateral and Unilateral Truncal Vagotomy and Substance P.
    Kodama Y; Sasaki K; Murasato F; Overby A; Takahashi S; Murayama SY; Matsui H; Nakamura M
    Curr Pharm Des; 2018; 24(18):1961-1965. PubMed ID: 29766790
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Aprepitant for the Treatment of Chronic Refractory Pruritus.
    He A; Alhariri JM; Sweren RJ; Kwatra MM; Kwatra SG
    Biomed Res Int; 2017; 2017():4790810. PubMed ID: 29057261
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Addition of 3-day aprepitant to ondansetron and dexamethasone for prophylaxis of chemotherapy-induced nausea and vomiting among patients with diffuse large B cell lymphoma receiving 5-day cisplatin-based chemotherapy.
    Abdel-Malek R; Abbas N; Shohdy KS; Ismail M; Fawzy R; Salem DS; Safwat E
    J Egypt Natl Canc Inst; 2017 Sep; 29(3):155-158. PubMed ID: 28844591
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature.
    Song JS; Tawa M; Chau NG; Kupper TS; LeBoeuf NR
    BMC Cancer; 2017 Mar; 17(1):200. PubMed ID: 28302100
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Itch Management: Treatments under Development.
    Pereira MP; Ständer S
    Curr Probl Dermatol; 2016; 50():71-6. PubMed ID: 27578074
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Paraneoplastic pruritus presenting with Hodgkin's lymphoma: a case report.
    Villafranca JJ; Siles MG; Casanova M; Goitia BT; Domínguez AR
    J Med Case Rep; 2014 Sep; 8():300. PubMed ID: 25200537
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Treatment of pruritus in early-stage hypopigmented mycosis fungoides with aprepitant.
    Jiménez Gallo D; Albarrán Planelles C; Linares Barrios M; Fernández Anguita MJ; Márquez Enríquez J; Rodríguez Mateos ME
    Dermatol Ther; 2014; 27(3):178-82. PubMed ID: 24517320
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Synergism between fibronectin and transforming growth factor-β1 in the production of substance P in monocytes of patients with myelofibrosis.
    Chang VT; Yook C; Rameshwar P
    Leuk Lymphoma; 2013 Mar; 54(3):631-8. PubMed ID: 22906243
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Expression and proliferative effect of hemokinin-1 in human B-cells.
    Grassin-Delyle S; Buenestado A; Vallat L; Naline E; Marx S; Decocq J; Debré P; Bernard OA; Advenier C; Devillier P; Merle-Béral H
    Peptides; 2011 May; 32(5):1027-34. PubMed ID: 21334411
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The NK-1 receptor is expressed in human leukemia and is involved in the antitumor action of aprepitant and other NK-1 receptor antagonists on acute lymphoblastic leukemia cell lines.
    Muñoz M; González-Ortega A; Coveñas R
    Invest New Drugs; 2012 Apr; 30(2):529-40. PubMed ID: 21120581
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Mimicry between neurokinin-1 and fibronectin may explain the transport and stability of increased substance P immunoreactivity in patients with bone marrow fibrosis.
    Rameshwar P; Joshi DD; Yadav P; Qian J; Gascon P; Chang VT; Anjaria D; Harrison JS; Song X
    Blood; 2001 May; 97(10):3025-31. PubMed ID: 11342427
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.